Jessica Sachs - 31 Dec 2021 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Medical Officer
Signature
/s/ Ryan Murr, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
31 Dec 2021
Net transactions value
+$4,595
Form type
4
Filing time
04 Jan 2022, 20:25:17 UTC
Next filing
27 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COGT Common Stock Award $4,595 +674 $6.82 674 31 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).